Abbott/$ABT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Abbott
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Ticker
$ABT
Sector
Primary listing
NYSE
Employees
114,000
Headquarters
Website
Abbott Metrics
BasicAdvanced
$223B
16.07
$7.96
0.70
$2.32
1.84%
Price and volume
Market cap
$223B
Beta
0.7
52-week high
$141.23
52-week low
$110.86
Average daily volume
6.3M
Dividend rate
$2.32
Financial strength
Total debt to equity
26.501
Interest coverage (TTM)
15.95%
Profitability
EBITDA (TTM)
11,623
Gross margin (TTM)
56.14%
Net profit margin (TTM)
31.88%
Operating margin (TTM)
19.35%
Effective tax rate (TTM)
-71.75%
Revenue per employee (TTM)
$380,000
Management effectiveness
Valuation
Price to earnings (TTM)
16.074
Price to revenue (TTM)
5.078
Price to book
4.4
Price to tangible book (TTM)
10.76
Dividend yield (TTM)
1.81%
Forward dividend yield
1.84%
Growth
Revenue change (TTM)
6.37%
Earnings per share change (TTM)
141.96%
3-year revenue growth (CAGR)
-0.89%
10-year revenue growth (CAGR)
7.86%
3-year earnings per share growth (CAGR)
21.57%
10-year earnings per share growth (CAGR)
10.24%
3-year dividend per share growth (CAGR)
7.87%
10-year dividend per share growth (CAGR)
9.41%
What the Analysts think about Abbott
Analyst ratings (Buy, Hold, Sell) for Abbott stock.
Bulls say / Bears say
Abbott's medical device sales jumped 21.4% year-on-year to $1.9 billion in Q2 2025, driving total revenue to $11.14 billion and topping analyst projections, led by high demand for its continuous glucose monitors. (Reuters)
In Q1 2025, Abbott delivered adjusted EPS of $1.09, outperforming forecasts by $0.02, and confirmed its full-year profit guidance at $5.05–$5.25 per share, supported by strong demand in medical devices. (Reuters)
Abbott will invest $500 million to expand manufacturing and research operations in Illinois and Texas, aimed at reducing supply chain risk from tariffs and strengthening its long-term operational stability. (Reuters)
Abbott's Q1 2025 revenue was $10.36 billion, missing estimates by $40 million, mainly due to weakness in its diagnostics division. (Reuters)
Although Abbott beat Q2 earnings expectations, its shares fell more than 4% after the company released a Q3 profit outlook of $1.28–$1.32 per share, below the $1.34 average forecast, signaling possible deceleration. (Reuters)
Ongoing global tariff uncertainty focused on China is pressuring costs. With roughly 60% of sales coming from outside the U.S., Abbott also faces risks to margins and from currency movements. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.
Abbott Financial Performance
Revenues and expenses
Abbott Earnings Performance
Company profitability
Abbott News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Abbott stock?
Abbott (ABT) has a market cap of $223B as of October 23, 2025.
What is the P/E ratio for Abbott stock?
The price to earnings (P/E) ratio for Abbott (ABT) stock is 16.07 as of October 23, 2025.
Does Abbott stock pay dividends?
Yes, the Abbott (ABT) stock pays dividends to shareholders. As of October 23, 2025, the dividend rate is $2.32 and the yield is 1.84%. Abbott has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Abbott dividend payment date?
The next Abbott (ABT) dividend payment is scheduled for November 17, 2025.
What is the beta indicator for Abbott?
Abbott (ABT) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.